The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
2008
DOI: 10.1002/jms.1462
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis and identification of hydroxylated metabolites of the anti‐estrogenic agent cyclofenil

Abstract: The detection of metabolites of the anti-estrogenic substance cyclofenil, listed on the World Anti-Doping Agency (WADA) Prohibited List since 2004 is described. Target substances are hydroxylated metabolites, bearing an aliphatic hydroxyl group either in the 2-, 3-or 4-position of the aliphatic ring, in addition to the phenolic functions on the aromatic rings. Structural identification used NMR as well as high-resolution mass spectrometry after nano-electrospray ionisation (ESI). Unambiguous detection of all t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2008
2008
2013
2013

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 10 publications
(1 citation statement)
references
References 7 publications
0
1
0
Order By: Relevance
“…Since the consumption of these compounds by the athletes is prohibited in sport events, several screening procedures were developed for the detection of anti-estrogens in human urine for anti-doping purposes. Several GC/MS screening procedures applied to anti-estrogenic agents were developed [14] , [15] , [16] , [17] , even if an increasing number of procedures based on LC/MS have been published [18] , [19] , [20] , [21] , [22] . Anti-estrogenic agents are often screened together with other class of substances, mainly using LC-MS/MS procedures, usually more sensitive than GC/MS ones.…”
Section: Introductionmentioning
confidence: 99%
“…Since the consumption of these compounds by the athletes is prohibited in sport events, several screening procedures were developed for the detection of anti-estrogens in human urine for anti-doping purposes. Several GC/MS screening procedures applied to anti-estrogenic agents were developed [14] , [15] , [16] , [17] , even if an increasing number of procedures based on LC/MS have been published [18] , [19] , [20] , [21] , [22] . Anti-estrogenic agents are often screened together with other class of substances, mainly using LC-MS/MS procedures, usually more sensitive than GC/MS ones.…”
Section: Introductionmentioning
confidence: 99%